Business Wire

Worldwide Point of Care Diagnostic Industry to 2027 – Players Include Sysmex, Abbott Laboratories and Danaher Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Point of Care Diagnostic Market Size, Global Forecast 2021-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” report has been added to ResearchAndMarkets.com’s offering.

This report provides in-depth analysis on the Point of care global industry. The global point of care diagnostics market will be $44 Billion by 2027. The industry will grow at a CAGR of 7.17% during 2021-2027.

Companies Mentioned

  • Sysmex
  • Abbott Laboratories (US)
  • Becton Dickinson and Company (US)
  • Danaher Corporation (US)
  • Quidel Diagnostics (US)

Worldwide Point of Care Diagnostics Market Size was US$ 29.04 Billion in 2021

Around the world, testing devices have been designed for point of care with reduced footprints and ability to analyze a larger range of biomarkers, making them more flexible than machinery in the central laboratory. Portability and versatility have expanded POC testing’s capability; diagnoses are conducted in less traditional places, such as lower-income and under-served populations, rural regions, and areas with limited infrastructure.

Furthermore, the factors that drive the global Point of Care diagnostic are the surging prevalence of diseases which demand for better treatment and rapid diagnostic services. Staff shortages in clinical laboratories are primarily driving the demand for POC diagnostics.

United States Point of Care Diagnostics Market has the Lion’s Share

In this report we have covered by Country such as the United States, China, Japan, United Kingdom, Germany, Spain, Italy, Argentina, India, Brazil, Canada, and Mexico. The United States holds the dominant position across countries covered in this report and expected to continue its dominance during forecast period.

The factors that contribute to this country’s growth are the surging geriatric population base in the country, rising prevalence of diseases, and the favorable government regulations and initiatives undertaken to develop healthcare infrastructure. Emerging countries has been growing continuously and tend to do well during the forecast period as suggested by our analyst.

COVID-19 Impact on Point of Care Diagnostics Industry

Around the world, industries have been impacted by COVID-19 pandemic outbreak due to lockdowns, restrictions, and unavailability of transportation. But point of care diagnostics technologies has grown many folds. With many technologies approved during the pandemic for commercialization in the past 10 months, the field of COVID-19 POC diagnostics is rapidly evolving. As such, worldwide companies are in search of developing these devices to provide a reliable method of virus detection. The point of care market has multiplied during the pandemic and will surge post-recovery as expected.

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamic

4.1 Growth Drivers

4.2 Challenges

5. Global Point of Care Diagnostics Market

6. Market Share Analysis

6.1 Diagnostics Types

6.2 Technology

6.3 End User

6.4 Regions

7. Diagnostics Types – Global Point of Care Diagnostics Market

7.1 Glucose Monitoring

7.2 Infectious Disease

7.3 Pregnancy & Fertility Testing Market

7.4 Hermatology Testing

7.5 Cardiometabolic Monitoring

7.6 Coagulation Monitoring

7.7 Urinalysis

7.8 Tumor Markers

8. Technology – Global Point of Care Diagnostics Market

8.1 Biosensor

8.2 Lateral Flow

8.3 Agglutination

8.4 Flow Through

8.5 Solid phase

9. End User – Global Point of Care Diagnostics Market

9.1 Hospital

9.2 Clinics

9.3 Diagnostic centers

9.4 Others (Medical universities, Not-for-profit organizations, and Nursing homes)

10. Country – Global Point of Care Diagnostics Market

10.1 United States

10.2 China

10.3 Japan

10.4 United Kingdom

10.5 Germany

10.6 Spain

10.7 Italy

10.8 Argentina

10.9 India

10.10 Brazil

10.11 Canada

10.12 Mexico

11. Companies Profile

For more information about this report visit https://www.researchandmarkets.com/r/cvb13b

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker